Detalles de la búsqueda
1.
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
Thorax
; 79(3): 202-208, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328279
2.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 24(1): 229, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749551
3.
High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study.
Mod Rheumatol
; 32(1): 87-95, 2022 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856975
4.
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 25(1): 152, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561735
5.
Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 198(4): 464-471, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474094
6.
Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data.
Thorax
; 73(9): 877-879, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438071
7.
Presentation, management and mortality after a first MI in people with and without asthma: A study using UK MINAP data.
Chron Respir Dis
; 15(1): 60-70, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28393591
8.
Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM).
Health Qual Life Outcomes
; 12: 154, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25767846
9.
Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan.
Respir Investig
; 62(4): 685-694, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796907
10.
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.
Int J Chron Obstruct Pulmon Dis
; 19: 945-956, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38646606
11.
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.
BMJ Open Respir Res
; 11(1)2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772900
12.
Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
Respir Med
; 226: 107630, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593886
13.
Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
Respir Med
; 226: 107629, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593885
14.
Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records.
PLoS One
; 18(11): e0292876, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37910484
15.
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review.
Int J Chron Obstruct Pulmon Dis
; 18: 719-731, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151760
16.
Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study.
Adv Ther
; 40(11): 4857-4876, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698717
17.
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.
Int J Chron Obstruct Pulmon Dis
; 18: 2673-2685, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022832
18.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting ß2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Int J Chron Obstruct Pulmon Dis
; 18: 643-659, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155496
19.
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.
Int J Chron Obstruct Pulmon Dis
; 18: 2933-2953, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089540
20.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Int J Chron Obstruct Pulmon Dis
; 18: 2039-2054, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731774